Cooper MR - Search Results

1

Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation.

LaRocca RV, Cooper MR, Uhrich M, Danesi R, Walther MM, Linehan WM, Myers CE. LaRocca RV, et al. Among authors: cooper mr. Urol Clin North Am. 1991 Feb;18(1):123-9. Urol Clin North Am. 1991. PMID: 1992566 Review.

2

Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer.

Myers C, Cooper M, Stein C, LaRocca R, Walther MM, Weiss G, Choyke P, Dawson N, Steinberg S, Uhrich MM, et al. Myers C, et al. J Clin Oncol. 1992 Jun;10(6):881-9. doi: 10.1200/JCO.1992.10.6.881. J Clin Oncol. 1992. PMID: 1375283 Clinical Trial.

3

Suramin inhibits proliferation and DNA synthesis in transitional carcinoma cell lines.

Walther MM, Trahan EE, Cooper M, Venzon D, Linehan WM. Walther MM, et al. J Urol. 1994 Nov;152(5 Pt 1):1599-602. doi: 10.1016/s0022-5347(17)32486-2. J Urol. 1994. PMID: 7933214

4

A pilot study of suramin in the treatment of progressive refractory follicular lymphomas.

La Rocca RV, Cooper MR, Stein CA, Kohler D, Uhrich M, Weinberger E, Myers CE. La Rocca RV, et al. Among authors: cooper mr. Ann Oncol. 1992 Jul;3(7):571-3. Ann Oncol. 1992. PMID: 1498080 Free article. Clinical Trial.

5

Suramin in advanced platinum-resistant ovarian cancer.

Reed E, Cooper MR, LaRocca RV, Bostick-Bruton F, Myers CE. Reed E, et al. Among authors: cooper mr. Eur J Cancer. 1992;28A(4-5):864-6. doi: 10.1016/0959-8049(92)90135-o. Eur J Cancer. 1992. PMID: 1524910 Clinical Trial.

6

Effect of suramin on human prostate cancer cells in vitro.

La Rocca RV, Danesi R, Cooper MR, Jamis-Dow CA, Ewing MW, Linehan WM, Myers CE. La Rocca RV, et al. Among authors: cooper mr. J Urol. 1991 Feb;145(2):393-8. doi: 10.1016/s0022-5347(17)38351-9. J Urol. 1991. PMID: 1824865

7

A pilot study of suramin in the treatment of metastatic renal cell carcinoma.

La Rocca RV, Stein CA, Danesi R, Cooper MR, Uhrich M, Myers CE. La Rocca RV, et al. Among authors: cooper mr. Cancer. 1991 Mar 15;67(6):1509-13. doi: 10.1002/1097-0142(19910315)67:6<1509::aid-cncr2820670608>3.0.co;2-f. Cancer. 1991. PMID: 2001538

8

Anaphylactoid reaction with suramin.

Thibault A, Figg WD, Cooper MR, Prindiville SA, Sartor AO, Headlee DJ, Myers CE. Thibault A, et al. Among authors: cooper mr. Pharmacotherapy. 1993 Nov-Dec;13(6):656-7. Pharmacotherapy. 1993. PMID: 8302692

9

The effect of suramin on laboratory tests of coagulation.

Horne MK 3rd, Wilson OJ, Cooper M, Gralnick HR, Myers CE. Horne MK 3rd, et al. Thromb Haemost. 1992 Apr 2;67(4):434-9. Thromb Haemost. 1992. PMID: 1631791

10

A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: toxicity and response.

Bowden CJ, Figg WD, Dawson NA, Sartor O, Bitton RJ, Weinberger MS, Headlee D, Reed E, Myers CE, Cooper MR. Bowden CJ, et al. Among authors: cooper mr. Cancer Chemother Pharmacol. 1996;39(1-2):1-8. doi: 10.1007/s002800050531. Cancer Chemother Pharmacol. 1996. PMID: 8995493 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

319 results

Search Page